A critical advance in cancer study is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This essential tumor suppressor protein is frequently inactivated in various forms of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research